Musk vs Altman - The Altman Network

This is a concepts and analysis page. It documents what was presented at trial, compares it to what this investigation has found independently, and flags discrepancies or gaps where trial testimony and our documentation do not align. The trial has concluded. The jury ruled against Musk on statute of limitations grounds without reaching the merits. Musk is appealing. We are not attempting to change the outcome — we are comparing the public record of the trial to the documentary record of this investigation.

Trial Summary

Field	Detail
Case	Musk v. Altman et al.
Court	U.S. District Court, Northern District of California (Oakland)
Judge	Yvonne Gonzalez Rogers
Jury	9 members (6 women, 3 men), advisory verdict
Trial dates	April 27 – May 18, 2026
Verdict	Unanimous: claims filed outside 3-year statute of limitations
Deliberation time	Less than 2 hours
Damages sought	Up to $150 billion disgorgement, removal of Altman and Brockman, dismantling of for-profit entity
Ruling on merits	Never reached. The jury and judge never ruled on whether Altman and OpenAI violated the nonprofit mission.
Key witnesses	Elon Musk (Apr 28-30), Greg Brockman (May 5-6), Shivon Zilis (May 7), Satya Nadella (May 11), Ilya Sutskever (May 11), Bret Taylor (May 12), Zico Kolter (May 12), Sam Altman (May 12-13)
Musk’s response	“Calendar technicality.” Deleted a post calling judge a “terrible activist Oakland judge.” Lawyer Marc Toberoff: “appeal.”

[1] [2] [3]

Witness Testimony — Key Details

Elon Musk (April 28-30)

Musk testified that he is “not entirely against OpenAI having a for-profit unit” but said it became “the tail wagging the dog.” He accused Altman and Brockman of enriching themselves from a charity while reaping positive associations from running a nonprofit. Two days before the trial, Musk texted Brockman to gauge the possibility of settlement. In text messages included in a court filing, Musk vowed to make Brockman and Altman “the most hated men in America” through evidence presented at trial. [12] [13]

Greg Brockman (May 5-6)

Brockman disclosed that his stake in OpenAI is worth approximately $30 billion. Musk’s attorney Marc Molo mentioned this figure “more than a dozen times” during questioning and asked: “Do you believe that your nearly $30 billion stake breaches your duty to humanity?” Brockman responded: “No, I believe that we have developed the most well-capitalized nonprofit in human history.” [13]

Molo asked why Brockman had not donated the other $29 billion worth of equity back to the nonprofit foundation. Brockman didn’t have a straightforward answer. [12]

The diary entries: Musk’s lawyers introduced entries from Brockman’s personal journal. In a September 2017 entry, as he pondered OpenAI’s future, Brockman wrote: “Financially, what will take me to $1B?” He also wrote: “Some chance that rejecting Elon will actually lose us Sam. We’ll find out tomorrow if doing an override all the way through is palatable.” Brockman testified the journal was for processing decisions and was written only for himself. He described public disclosure as “very painful” but said “there was nothing in there that I’m ashamed of.” [13] [14]

Brockman testified about an August 2017 meeting where cofounders gathered to discuss for-profit restructuring. Ilya Sutskever arrived with a painting of a Tesla as a “token of goodwill” in return for actual Teslas Musk had given them days earlier. “It felt a little bit like [Musk] was buttering us up, that he wanted us to feel indebted to him,” Brockman told the jury. When Brockman and Sutskever proposed equal equity shares, Musk fell silent, said “I decline,” stood up, and “stormed around the table.” Brockman testified: “I actually thought he was going to hit me.” Musk grabbed the painting and walked out. [15]

Brockman also testified that Musk never expressed interest in open-sourcing OpenAI’s technology. “Honestly, it was not a topic of conversation.” [12]

Shivon Zilis (May 7)

Zilis, a former OpenAI board member and the mother of four of Musk’s children, testified about her role during a critical six-week period when founders discussed alternative structures. She met Musk while working as an informal advisor at OpenAI in 2016 and described a “one-off” romantic encounter. She joined Tesla and Neuralink in 2017, then joined OpenAI’s board in 2020. She became pregnant with Musk’s children through IVF but did not disclose her ties with Musk to OpenAI until Business Insider reported them in 2022. [15]

OpenAI’s lawyers argued Zilis acted as a “conduit” for Musk, feeding information back to him and facilitating his effort to poach OpenAI’s cofounders for a new AI lab within Tesla. [15] [16]

Satya Nadella (May 11)

Microsoft’s CEO testified that Musk never contacted him with concerns that Microsoft’s investments violated any special terms. Nadella testified that OpenAI retained its independence even as the partnership deepened: “OpenAI had all the rights and resources they always had.” [12]

During the November 2023 firing, Nadella offered to create a separate AI project for Altman, Brockman, and potentially departing employees — an attempt to prevent OpenAI’s implosion and protect Microsoft’s investments. Former board member Tasha McCauley recalled in a videotaped deposition that “Satya wanted to restore things.” [12] [17]

Ilya Sutskever (May 11)

OpenAI’s former chief scientist disclosed that his stake in OpenAI’s for-profit arm is worth approximately $7 billion. Sutskever was one of the board members who voted to fire Altman in November 2023, then reversed course. He later departed OpenAI entirely. [17]

Sam Altman (May 12-13)

Altman testified: “I was not trying to deceive the board. I was certainly not trying to do anything other than make safe AI and distribute it to humanity. I feel badly for the misunderstandings.” [14]

On the Helion conflict: Musk’s attorney pressed Altman about personal investments in startups doing business with OpenAI. Altman testified he tried to steer OpenAI to buying power from Helion Energy, in which he owns approximately one-third. He acknowledged that “a huge percentage” of his time at OpenAI was spent securing energy and compute resources, which he was doing while also chairing Helion’s board. He said he recused himself from a potential deal but acknowledged awareness of a second agreement in March 2026. [5] [6]

What Altman was NOT asked about (in available trial coverage): Formation Bio pipeline, OpenResearch grants to TrialSpark, Project Covalence, Retro Biosciences, Worldcoin governance, the AltC SPAC, or the broader pattern of nonprofit-to-personal-profit conversion across his investment portfolio.

Other Unsealed Evidence

Brockman diary — prediction market impact: Betting odds for Musk’s case reached as high as 60% on Polymarket after the diary entries were unsealed, before dropping to 28-36% ahead of the verdict. The “$1B” entry was described as sitting “at the heart of Musk’s case.” [18]

Mark Zuckerberg texts: Court filings revealed that Meta’s CEO privately offered Musk help with DOGE coverage and discussed a joint bid for OpenAI IP. [14]

Musk’s October 2020 public complaint: “This does seem like the opposite of open. OpenAI is essentially captured by Microsoft.” This tweet was introduced as evidence that Musk was aware of concerns years before filing suit in 2024 — supporting the statute of limitations defense. [17]

What the Trial Addressed

1. The Nonprofit-to-For-Profit Conversion

The central allegation: Musk claimed his ~$38 million in donations were conditioned on OpenAI remaining a nonprofit. OpenAI argued Musk knew about for-profit plans as early as 2017-2018 and that Altman sent Musk documents in 2018 outlining plans to raise billions through a for-profit structure. [4]

Our investigation’s parallel documentation: The nonprofit-to-for-profit (or reverse) conversion is not unique to OpenAI. We have documented the identical pattern at 23andMe/TTAM (for-profit → bankruptcy → founder creates nonprofit → reacquires assets at 91% discount) and at OpenResearch (nonprofit funding for-profit operations through the $1M TrialSpark grant). Public Citizen independently used the word “self-dealing” to describe both the OpenAI and 23andMe transitions.

2. Altman’s Personal Conflicts of Interest

Musk’s attorney pressed Altman about personal investments in startups that do business with OpenAI. Altman testified that he tried to steer OpenAI to buying power from Helion Energy, a nuclear fusion company in which he owns approximately one-third. [5]

Altman acknowledged that “a huge percentage” of his time at OpenAI was spent securing energy and compute resources — which he was doing while also chairing Helion’s board. He said he recused himself from a potential deal between Helion and OpenAI, though he acknowledged awareness of a second agreement in March 2026. [6]

What the trial did NOT address (from our investigation):

Conflict	Trial Coverage	Investigation Documentation
Helion Energy	Addressed directly. Altman testified about recusal.	Altman stepped down as Helion chairman March 2026 specifically to allow OpenAI/Helion deal.
Oklo (nuclear)	Mentioned in context	Altman chaired Oklo board 2015-April 2025, took it public via his own AltC SPAC. Stepped down to allow Oklo-OpenAI partnerships.
Formation Bio	Appeared on court exhibit ($19M stake per Reuters)	$1M OpenResearch nonprofit grant → personal $156M Series C investment. OpenAI/Sanofi/Formation Bio Muse partnership. No Form D for $250M+ in fundraising. Moritz as board director.
Retro Biosciences	Not addressed in available trial coverage	$180M personal investment (“all my liquid net worth”). Same anti-aging therapeutic area as resTORbio/Project Covalence. Trial in Australia.
Worldcoin	Not addressed in available trial coverage	Iris scanning in developing nations. Co-investor list includes convicted fraudsters (SBF, Three Arrows). Banned/regulated in 7+ countries.
OpenResearch → TrialSpark grant	Not addressed in available trial coverage	$1M nonprofit grant to for-profit company where Altman was already an investor. Only grant issued that year. Purpose: “Operations.”

The Helion testimony is the only documented conflict that was directly examined at trial. The broader pattern — Formation Bio, Retro, Worldcoin, OpenResearch — represents a significantly larger universe of conflicts that the jury never heard.

3. The Brockman Overlap

The House Oversight Committee’s May 8 letter revealed that Greg Brockman holds stakes in two startups that Altman backs and holds a percentage of Altman’s family fund — disclosed through litigation discovery. [7]

Our investigation’s documentation: Brockman donated $50 million to political causes. He and his wife each donated $12.5 million to Trump’s MAGA Inc. super PAC. The Brockman-Altman financial overlap extends beyond OpenAI into personal investment vehicles.

4. The November 2023 Firing

The trial addressed the “Blip” — Altman’s firing by the OpenAI board on November 17, 2023 and reinstatement on November 22, 2023. The original board stated Altman was “not consistently candid in his communications with the board.” [8]

Our investigation’s documentation: The board members who questioned Altman’s conflicts (Helen Toner, Tasha McCauley, Ilya Sutskever) were removed. The new board (Bret Taylor, Larry Summers, Adam D’Angelo) was installed. An internal audit committee was created to review conflicts — its findings were never publicly disclosed. The House Oversight Committee is now demanding those findings. [7]

What the Trial Did NOT Address

These are areas documented in our investigation that do not appear in available trial coverage:

A. The OpenResearch → TrialSpark → Formation Bio Pipeline

The trial showed Altman’s $19M Formation Bio stake on a court exhibit. But the pipeline behind that stake — nonprofit money ($1M from OpenResearch) flowing to a for-profit company (TrialSpark) where Altman was already an investor, followed by Altman personally leading a $156M Series C, followed by an OpenAI commercial partnership (Muse) with the same company — was not examined in available trial testimony.

What this means for the appeal: If the merits are ever reached, the Formation Bio pipeline represents a more complete picture of the nonprofit-to-personal-profit conversion than Helion alone. Helion is an energy deal. Formation Bio is a direct pipeline from Altman’s nonprofit to his personal investment portfolio through a clinical trial company that tested failed drugs on nursing home patients.

B. The Project Covalence Arc

The $1M OpenResearch grant funded TrialSpark’s Project Covalence platform, which tested a failed anti-aging drug (RTB-101) on elderly nursing home residents through a company (resTORbio) that had already signed its own dissolution agreement. The study terminated. Results were never published. Altman then led a $156M personal investment in the platform company.

None of this appears in available trial coverage.

C. The Brad Lightcap Recusal Proxy

Altman testified about recusing from the Helion deal. But the structural question is broader: Brad Lightcap (OpenAI COO) is the named recusal proxy for every Altman conflict. Lightcap handled the Formation Bio/Sanofi/OpenAI Muse partnership. In April 2026, Lightcap moved to “special projects” reporting directly to Altman.

The recusal mechanism: Altman recuses → Lightcap acts → Lightcap reports to Altman. This is delegation of the appearance of recusal, not separation of interest. The trial addressed Altman’s self-described recusal from Helion but did not examine whether the recusal infrastructure across ALL conflicts is structurally adequate.

D. The Audit Committee Findings

OpenAI’s board created an audit committee to investigate Altman’s conflicts after the November 2023 firing. The findings were never publicly disclosed. The House Oversight Committee’s May 8 letter demanded all documents related to the audit committee. As of the trial’s conclusion, those findings remain undisclosed. [7]

The question: What did the audit committee find? If it found no conflicts, why wasn’t the finding disclosed to resolve public concern? If it found conflicts, why wasn’t action taken? The trial proceeded without the audit committee’s conclusions being part of the record.

E. The 12 Former Employees’ Amicus Brief

In April 2025, twelve former OpenAI employees filed an amicus brief through Harvard law professor Lawrence Lessig, stating that Altman “was a person of low integrity who had directly lied to employees about the extent of his knowledge and involvement in OpenAI’s practices of forcing departing employees to sign lifetime non-disparagement agreements.” [9]

This is an extraordinary filing — former employees of the company at issue, represented by one of America’s most respected legal scholars, calling the CEO “a person of low integrity” and accusing him of lying. The weight of this filing in the context of the statute-of-limitations dismissal is significant: the merits were never reached, but the character evidence exists in the court record.

The Statute of Limitations Defense

The jury found that Musk’s claims were filed outside the three-year statute of limitations. Musk argued his concerns “fully crystallised” only in 2023 with Microsoft’s large investments. OpenAI argued Musk knew about for-profit plans since 2017-2018. [1] [4]

From our investigation: The for-profit infrastructure was being built well before 2023:

2019: For-profit subsidiary created with “capped-profit” model
2020: $1M OpenResearch grant to TrialSpark (nonprofit funding for-profit operations)
2021: Altman leads $156M Series C in TrialSpark using “CEO of OpenAI” title
2021: AltC SPAC co-founded with Michael Klein
October 2025: OpenAI completed formal PBC restructuring (nonprofit retained 26% equity stake)

The question for the appeal: was Musk’s knowledge of general for-profit discussions (2017-2018) the same as knowledge of the specific self-dealing patterns that only became documentable through later filings and reporting?

The House Oversight Investigation

Launched during the trial (May 8, 2026), Rep. James Comer’s letter to Altman: [7] [10]

Investigating “potential conflicts of interest involving capital from nonprofit corporations invested in startups and other for-profit companies”
Focus: “whether such investments are used to artificially inflate valuations”
Demands: All audit committee documents and communications, 2015-present
Deadline: May 22, 2026 closed-door briefing
Specific concerns: Helion deal at “lofty valuation,” Brockman’s stakes in Altman-backed startups

Republican state AGs separately called on the SEC to review Altman’s conflicts ahead of OpenAI’s planned IPO. [6]

From our investigation: The House Oversight investigation is asking exactly the questions our documentation addresses — nonprofit capital being used to inflate for-profit valuations. The OpenResearch → TrialSpark → Formation Bio pipeline is a direct example: $1M from a nonprofit, followed by a $156M personal investment that inflated existing investors’ positions (Moritz’s Crankstart went from $4.3M to $75.1M on the Series C).

Nodes and Open Questions

Formation Bio at trial: The $19M stake appeared on a court exhibit (Reuters). Was the full pipeline (OpenResearch grant → Project Covalence → Series C → Muse partnership) presented to the jury, or only the current dollar figure?
The undisclosed audit committee findings: What did the internal review find? The House Oversight Committee is demanding these documents. If they surface during the appeal or congressional investigation, they could change the evidentiary landscape.
Lightcap as recusal proxy: Was the structural adequacy of Altman’s recusal mechanism examined at trial, or only the specific Helion recusal? Lightcap now reports directly to Altman (“special projects,” April 2026).
The Lessig amicus brief: Twelve former employees calling Altman “a person of low integrity” through a Harvard law professor. If the appeal reaches the merits, this character evidence is already in the record.
The SoftBank contingency: SoftBank committed $40B to OpenAI contingent on for-profit conversion by year-end. The trial verdict removes a legal obstacle to that conversion. Was the timing of the expedited trial itself influenced by the SoftBank deadline?
Musk’s contradictions: Musk proposed folding OpenAI into Tesla (for-profit) and made a $97.4B takeover bid (for-profit). OpenAI used both against him. The investigation notes Musk’s inconsistency without endorsing his position — his contradictions don’t negate Altman’s conflicts.
What the jury never decided: The merits were never reached. The jury decided when Musk knew, not whether what Altman did was wrong. Every question about nonprofit conversion, self-dealing, conflicts of interest, and the OpenResearch pipeline remains unanswered by the court.